PSNL
Price
$6.58
Change
+$0.21 (+3.30%)
Updated
Jun 27 closing price
Capitalization
75.25M
38 days until earnings call
XRAY
Price
$15.93
Change
-$0.07 (-0.44%)
Updated
Jun 27 closing price
Capitalization
6.69B
32 days until earnings call
Interact to see
Advertisement

PSNL vs XRAY

Header iconPSNL vs XRAY Comparison
Open Charts PSNL vs XRAYBanner chart's image
Personalis
Price$6.58
Change+$0.21 (+3.30%)
Volume$9.94M
Capitalization75.25M
DENTSPLY SIRONA
Price$15.93
Change-$0.07 (-0.44%)
Volume$3.05M
Capitalization6.69B
PSNL vs XRAY Comparison Chart in %
Loading...
PSNL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PSNL vs. XRAY commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PSNL is a Buy and XRAY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (PSNL: $6.58 vs. XRAY: $15.93)
Brand notoriety: PSNL and XRAY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: PSNL: 943% vs. XRAY: 110%
Market capitalization -- PSNL: $75.25M vs. XRAY: $6.69B
PSNL [@Medical Specialties] is valued at $75.25M. XRAY’s [@Medical Specialties] market capitalization is $6.69B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PSNL’s FA Score shows that 0 FA rating(s) are green whileXRAY’s FA Score has 1 green FA rating(s).

  • PSNL’s FA Score: 0 green, 5 red.
  • XRAY’s FA Score: 1 green, 4 red.
According to our system of comparison, PSNL is a better buy in the long-term than XRAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PSNL’s TA Score shows that 5 TA indicator(s) are bullish while XRAY’s TA Score has 3 bullish TA indicator(s).

  • PSNL’s TA Score: 5 bullish, 4 bearish.
  • XRAY’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, PSNL is a better buy in the short-term than XRAY.

Price Growth

PSNL (@Medical Specialties) experienced а +2.80% price change this week, while XRAY (@Medical Specialties) price change was +4.76% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.08%. For the same industry, the average monthly price growth was +1.35%, and the average quarterly price growth was -0.23%.

Reported Earning Dates

PSNL is expected to report earnings on Aug 06, 2025.

XRAY is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (+1.08% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XRAY($6.69B) has a higher market cap than PSNL($75.3M). PSNL YTD gains are higher at: 13.841 vs. XRAY (-14.346). XRAY has higher annual earnings (EBITDA): 249M vs. PSNL (-96.81M). XRAY has more cash in the bank: 334M vs. PSNL (114M). PSNL has less debt than XRAY: PSNL (47.7M) vs XRAY (2.3B). XRAY has higher revenues than PSNL: XRAY (3.97B) vs PSNL (73.5M).
PSNLXRAYPSNL / XRAY
Capitalization75.3M6.69B1%
EBITDA-96.81M249M-39%
Gain YTD13.841-14.346-96%
P/E RatioN/A19.23-
Revenue73.5M3.97B2%
Total Cash114M334M34%
Total Debt47.7M2.3B2%
FUNDAMENTALS RATINGS
PSNL vs XRAY: Fundamental Ratings
PSNL
XRAY
OUTLOOK RATING
1..100
8917
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
3
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9796
PRICE GROWTH RATING
1..100
3462
P/E GROWTH RATING
1..100
10089
SEASONALITY SCORE
1..100
n/a30

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XRAY's Valuation (3) in the Medical Specialties industry is somewhat better than the same rating for PSNL (38) in the null industry. This means that XRAY’s stock grew somewhat faster than PSNL’s over the last 12 months.

XRAY's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as PSNL (100) in the null industry. This means that XRAY’s stock grew similarly to PSNL’s over the last 12 months.

XRAY's SMR Rating (96) in the Medical Specialties industry is in the same range as PSNL (97) in the null industry. This means that XRAY’s stock grew similarly to PSNL’s over the last 12 months.

PSNL's Price Growth Rating (34) in the null industry is in the same range as XRAY (62) in the Medical Specialties industry. This means that PSNL’s stock grew similarly to XRAY’s over the last 12 months.

XRAY's P/E Growth Rating (89) in the Medical Specialties industry is in the same range as PSNL (100) in the null industry. This means that XRAY’s stock grew similarly to PSNL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PSNLXRAY
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 7 days ago
54%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
75%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
56%
MACD
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
61%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
72%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 5 days ago
58%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 17 days ago
70%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
56%
Aroon
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
PSNL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ETB14.400.11
+0.77%
Eaton Vance Tax-Managed Buy-Write Income Fund
SPYV52.110.18
+0.35%
SPDR® Portfolio S&P 500 Value ETF
PPI16.310.01
+0.05%
Astoria Real Asset ETF
MBS8.66N/A
+0.05%
Angel Oak Mortgage-Backed Securities ETF
RING42.50-1.74
-3.93%
iShares MSCI Global Gold Miners ETF